Personalized medicine and therapeutic decision-making in oncology: a commentary on key environmental issues

Abstract

Get full access to this article

View all access options for this article.

References

Wang SS ‘New Cancer Drugs: Most Not Worth the Cost?’ Wall Street Journal Health Care Blog, http://blogs.wsj.com/health/2009/06/30/new-cancer-drugs-most-not-worth-the-cost/ (accessed June 2009)

100 Initial Priority Topics for Comparative Effectiveness Research . Institute of Medicine of the National Academies. http://www.iom.edu/Object.File/Master/71/032/Stand%20Alone%20List%20of%20100%20CER%20Priorities%20-%20for%20web.pdf (accessed June 2009).

Herceptin (trastuzumab). Full prescribing information. Genentech, Inc. May 2008.

Downs C. The Medicare Prescription Drug Improvement and Modernization Act and the delivery of cancer chemotherapy. Am J Health-Syst Pharm 2007; 64(supplement 10): 513-515.